The imperative of overcoming barriers to the conduct of large, simple trials

JAMA

Volumn 311, Issue 14, 2014, Pages 1397-1398

  Eapen, Zubin J ^a   Lauer, Michael S ^b   Temple, Robert J ^c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL STUDY; COST BENEFIT ANALYSIS; ELECTRONIC MEDICAL RECORD; FOOD AND DRUG ADMINISTRATION; FUNDING; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; OBSERVATIONAL STUDY; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SAFETY; SAMPLE SIZE; SAMPLING BIAS; SHORT SURVEY;

BIOLOGICAL MARKERS; DATA COLLECTION; DRUG EVALUATION; HUMANS; INDIVIDUALIZED MEDICINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84898748408     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.1030     Document Type: Short Survey

References (7)

1. Getz K. Clinical Trial Complexity. Institute of Medicine website. http://www.iom.edu/~/media/Files/Activity%20Files/Quality/VSRT/LST%20Workshop/ Presentations/Getz.pdf. November 2012. Accessed October 28, 2013.
2. US Food and Drug Administration (FDA). Guidance for Industry: Determining the Extent of Safety Data Collection Needed in Late Stage Premarket and Postapproval Clinical Investigations (Draft Guidance). FDA website. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM291158.pdf. February 2012. Accessed October 28, 2013.
3. US Food and Drug Administration (FDA). Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring. FDA website. http://www.fda.gov/downloads/Drugs/.../Guidances/UCM269919.pdf. August 2013. Accessed October 28, 2013.
4. US Food and Drug Administration (FDA). Guidance for Industry and Investigators: Safety Reporting Requirements for INDs and BA/BE Studies. FDA website. http://www.fda.gov/downloads/Drugs/.../Guidances/UCM227351.pdf. December 2012. Accessed October 28, 2013.
5. Fröbert O, Lagerqvist B, Olivecrona GK, et al TASTE Trial. Thrombus aspiration during ST-segment elevationmyocardial infarction. N Engl J Med. 2013;369(17):1587-1597.
6. Hess CN, Rao SV, Kong DF, et al. Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women). Am Heart J. 2013;166(3):421-428.
7. NIH Collaboratory website. https://www.nihcollaboratory.org/. Accessed October 2, 2013.